| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – |
| Gross Profit | – | – | – | – |
| Operating Expenses | $17.03M | $11.59M | $12.03M | $1.99M |
| R&D | $7.14M | $4.72M | $2.23M | $745.00K |
| SG&A | $9.89M | $6.86M | $5.25M | $1.25M |
| Operating Income | -$17.03M | -$11.59M | -$12.03M | -$1.99M |
| Interest Expense | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$16.71M | -$11.41M | -$15.43M | -$1.99M |
| EPS (basic) | -2.3200 | -6.4600 | -1.0500 | -0.1700 |
| EPS (diluted) | – | – | – | – |
| Shares (diluted) | – | – | – | – |